Promoter region polymorphism of the CD14 gene (C-159T) is not associated with psoriasis vulgaris

European Journal of Immunogenetics

Volumn 29, Issue 1, 2002, Pages 57-60

  Karhukorpi, J ^a,b   Ikaheimo I ^b   Karvonen, J ^b   Karttunen, R ^a  

^a UNIVERSITY OF OULU   (Finland)

^b OULU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN;

ALLELE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FINLAND; GENE CONTROL; GENE FREQUENCY; GENE FUNCTION; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MONOCYTE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN SECRETION; PSORIASIS VULGARIS; REGULATORY MECHANISM;

ANTIGENS, CD14; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSORIASIS;

EID: 0036166673     PISSN: 09607420     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0960-7420.2001.00282.x     Document Type: Article

References (28)

1. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach
2. A candidate gene for psoriasis near HLA-C, HCR (Pg8), is highly polymorphic with a disease-associated susceptibility allele
3. A polymorphism in the 5′ flanking region of the CD14 gene is associated with circulating soluble CD14 levels and with total serum immunoglobulin E
4. The genetics of psoriasis: A complex disorder of the skin and immune system
5. Advances in the search for psoriasis susceptibility genes
6. Human CD14 mediates recognition and phagocytosis of apoptotic cells
7. CD14-dependent clearance of apoptotic cells: Relevance to the immune system
8. Regulation of human monocyte apoptosis by the CD14 molecule
9. C (-260) → T polymorphism in the promoter region of the CD14 monocyte receptor gene as a risk factor for myocardial infarction
10. Expression of monocyte/macrophage markers (CD13, CD14, CD68) on human keratinocytes in healthy and diseased skin
11. Polymorphism in the promoter of lipopolysaccharide receptor CD14 and ischemic cerebrovascular disease
12. Elevated numbers of proliferating mononuclear cells in the peripheral blood of psoriatic patients correlate with disease severity
13. The influence of treatment on fibrin microclot generation in psoriasis
14. Polymorphism of the lipopolysaccharide receptor (CD14) and myocardial infarction. New evidence for a role of gram-negative bacterial infection?
15. Human monocyte CD14 is upregulated by lipopolysaccharide
16. Psoriasis and occlusive vascular disease
17. Role of increased production of monocyte TNF-α, IL-1β and IL-6 in psoriasis: Relation to focal infection, disease activity and responses to treatments
18. Psoriatic monocytes respond sensitively to lipopolysaccharide but with limited inflammatory cytokine production
19. Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasis
20. Psoriasis vulgaris, streptococci and the immune system: A riddle to be solved soon?
21. Combined analysis of polymorphisms of the tumor necrosis factor-α and interleukin-10 promoter regions and polymorphic xenobiotic metabolising enzymes in psoriasis
22. Soluble CD14 acts as a negative regulator of human T cell activation and function
23. Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages: Early membrane modifications and intracellular mycobacterial viability
24. Soluble CD14 monocyte antigen in suction blister fluid and serum of patients with psoriasis
25. An investigation of polymorphism in the interleukin-10 gene promoter
26. A new promoter polymorphism in the gene of lipopolysaccharide receptor CD14 is associated with expired myocardial infarction in patients with low atherosclerotic risk profile
27. Dermal injection of immunocytes induces psoriasis
28. Keratinocytes derived from psoriatic plaques are resistant to apoptosis compared with normal skin